ReviewFrontiers in oncology2024

Immune checkpoint inhibitors targeting PD-1/PD-L1 in the treatment of human lymphomas.

Domenico Ribatti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.